Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Evolent Health Inc (EVH) USD0.01

Sell:$9.49 Buy:$9.51 Change: $0.18 (1.86%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$9.49
Buy:$9.51
Change: $0.18 (1.86%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$9.49
Buy:$9.51
Change: $0.18 (1.86%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Evolent Health, Inc. is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company's platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models. The Company's services include providing its customers, with a population management platform, integrated data and analytics capabilities, pharmacy benefit management (PBM) services and comprehensive health plan administration services. Its value-based operations are empowered and supported by Identifi. Identifi is the Company's technology platform that aggregates and analyzes data, manages care workflows and engages patients.

Contact details

Address:
800 N Glebe Rd Ste 500
ARLINGTON
22203-2151
United States
Telephone:
+1 (571) 3896000
Website:
https://www.evolenthealth.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
EVH
ISIN:
US30050B1017
Market cap:
$803.80 million
Shares in issue:
84.61 million
Sector:
Health Care Technology
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Frank Williams
    Chairman of the Board, Chief Executive Officer
  • Seth Blackley
    President, Co-Founder, Director
  • John Johnson
    Chief Financial Officer
  • Thomas Peterson
    Chief Operating Officer
  • Nicholas McGrane
    Executive Vice President of Corporate Performance
  • Charles Pomeroy
    Chief Technology Officer
  • Lydia Stone
    Chief Accounting Officer, Corporate Controller
  • Jonathan Weinberg
    General Counsel
  • Dave Thornton
    Chief Talent Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.